Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02823002 · ClinicalTrials.gov registry record · NA

Pain Perception: Lidocaine Rate/Temp/Buffer

A NA study of Pain, sponsored by Northwestern University.

Active
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT02823002: Active NA study of Pain, sponsored by Northwestern University.

NCT02823002 is a NA study of Pain that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 26 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02823002, a NA study of Pain, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

This study will collect data from multiple academic institutions. The primary objective for part A of this study is to determine the impact of anesthetic injection rate and temperature on pain perception during dermatologic procedures, and the objective for the part B of this study is to determine if buffering of the anesthetic solution alters pain perception. This study is a pilot study designed to determine feasibility of these procedures.

Conditions Studied

Interventions

  • PROCEDURE Slow, Room Temperature Injection
  • PROCEDURE Rapid, Room Temperature Injection
  • PROCEDURE Slow, Warm Temperature Injection
  • PROCEDURE Rapid, Warm Temperature Injection
  • PROCEDURE Buffered Injection

Study Locations (1)

Illinois

  • Northwestern University Department of Dermatology - Chicago

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2016-06
Est. Completion 2025-01
Phase NA
Northwestern University

1,209 total trials

What the registry record for NCT02823002 still lists

NCT02823002 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 5 interventions - of which Slow, Room Temperature Injection is the first listed.

NCT02823002 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT02823002 about?

NCT02823002 is a clinical study titled "Pain Perception: Lidocaine Rate/Temp/Buffer". This study will collect data from multiple academic institutions. The primary objective for part A of this study is to determine the impact of anesthetic injection rate and temperature on pain perception during dermatologic procedures, and the objective for the part B of this study is to determine i...

What is the current status of trial NCT02823002?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2016-06. Estimated completion is 2025-01.

What conditions does trial NCT02823002 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT02823002?

The interventions under investigation include: Slow, Room Temperature Injection (PROCEDURE), Rapid, Room Temperature Injection (PROCEDURE), Slow, Warm Temperature Injection (PROCEDURE), Rapid, Warm Temperature Injection (PROCEDURE), Buffered Injection (PROCEDURE).

Who is sponsoring clinical trial NCT02823002?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02823002 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02823002's enrollment target sits among peer trials

26 318th of 374 higher than 55 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02823002, the US trial registry maintained by the National Library of Medicine. NCT02823002 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.